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Abstract
Introduction The regulation and elevation in expression of the
catabolic matrix metalloproteinases (MMPs) is of high
importance in the human intervertebral disc since upregulation
of these matrix-degrading enzymes results in matrix destruction
associated with disc degeneration. MMP28 (epilysin) is a newly
discovered MMP believed to play a role in matrix composition
and turnover in skin. It is present in basal keratinocytes where its
expression is upregulated with wound repair, and in cartilage
and synovium where it is upregulated in osteoarthritis. Recent
work has shown that mechanical compression can act to
modulate expression of MMP28. The expression of MMP28 is
unexplored in the intervertebral disc.
Methods Following approval by our human subjects institutional
review board, we employed microarray analyses to evaluate in
vivo expression of MMP28 and the MMP28 precursor in human
disc tissue, and utilized immunohistochemistry to determine
cellular and extracellular matrix localization of MMP28 in 35
human disc tissue specimens. The percentage of cells positive
for MMP28 immunocytochemical localization was also
determined.
Results The present work documents the expression and
presence of MMP28 in cells and extracellular matrix (ECM) of
the human intervertebral disc. Gene expression levels in human
disc tissue were detectable for both MMP28 and the MMP28
precursor. MMP28 cytoplasmic localization was present in cells
of the outer annulus; it was also present in some, but not all, cells
of the inner annulus and nucleus. MMP28 was not found in the
ECM of healthier Grade I to II discs, but was identified in the
ECM of 61% of the more degenerated Grade III to V discs (P =
0.0018). There was a significant difference in cellular MMP28
distribution in the disc (P = 0.008): the outer annulus showed
the largest percentage of cells positive for MMP28
immunolocalization, followed by the inner annulus and then the
nucleus. Herniated discs showed a significantly greater
proportion of MMP28-positive cells compared with
nonherniated discs (P = 0.034).
Conclusions Findings presented here show the first
documentation of intervertebral disc expression and production
of MMP28. MMP28 was found in both disc cell cytoplasm and
in the ECM of more degenerated specimens, with greater
cellular localization in the outer annulus and in herniated disc
specimens. These findings are important because of the key role
of MMPs in disc turnover and homeostasis, and previous
indications of a role for this MMP in matrix repair and matrix
turnover in other tissues. Our data, which show the presence of
MMP28 in human disc tissue, suggest that MMP28 may have a
potentially important role in ECM modulation in the healthy and
degenerating disc.
Introduction
The regulation and elevation in expression of the catabolic
matrix metalloproteinases (MMPs) is of high importance in the
human intervertebral disc since upregulation of these matrix-
degrading enzymes results in matrix destruction associated
with disc degeneration [1]. Historically, research has focused
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upon MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP13
and, more recently, MMP19 and MMP10 [2-12].
In the present study, we turned our attention to MMP28 (epi-
lysin), the newest member of the MMP family, discovered in
2001 by Lohi and colleagues [13] and also by Marchenko and
Strongin [14]. Related to our intervertebral disc interests, we
were especially interested to find data reporting that the induc-
tion of MMP28 requires epidermal injury, suggesting a role for
MMP28 in extracellular matrix (ECM) homeostasis [15].
Wound healing studies showed that MMP28 was spatially and
temporally regulated. Recent work by Renò and colleagues
has shown that mechanical compression can act to modulate
wound healing and also to modulate expression of MMP28
[16]. Mechanical compression significantly upregulated
MMP28 secretion in hypertrophic scars [16].
The closest relative of MMP28 at the amino acid sequence
level is MMP19 (which has recently been identified in the
human intervertebral disc [11]). MMP28 is a 59 kDa protein,
first identified in keratinocytes and testis, and expressed at
lower levels in the lung, heart, colon, intestine, bone, kidney,
brain and other tissues [13,17]. MMP28 has catalytic activity
as an endopeptidase and has the ability to degrade casein
[13], and to date this nonspecific substrate for many pro-
teases [18] is the only protein substrate reported for MMP28.
The MMP28 protein requires divalent cations for activity, and
was shown to be inhibited by a synthetic MMP inhibitor.
MMP28 does not include domains characteristic of other
MMP subfamilies (the disintegrin and thrombospondin-like
regions found in a disintegrin and metalloproteinase and in a
disintegrin and metalloproteinase with thrombospondin) or the
transmembrane group as found in membrane-type MMPs [13],
and the MMP28 promotor has a unique conserved GF-box
that is required for basal expression in keratinocytes [19].
Recent work by Werner and colleagues has shown that
MMP28 is upregulated during conditions of demyelation, sug-
gesting another in vivo role for MMP28 [20].
In the work reported in the present article, we investigated
whether MMP28 was expressed in the human intervertebral
disc. Our objectives were to determine whether MMP28 and
its precursor are expressed in vivo in human disc tissue, and
to assess the location of MMP28 in disc tissue using
immunohistochemistry.
Materials and methods
Clinical study population
Experimental study of disc specimens was approved prospec-
tively by the authors' Human Subjects Institutional Review
Board. Since disc surgeries are routinely performed in our
institution, and surgically removed tissue is discarded,
informed consent was not required. The Thompson grading
system is used to score disc degeneration over the spectrum
of stages from Thompson Grade I (a healthy disc) to discs with
advanced degeneration (Thompson Grade V) [21]. Patient
specimens were derived from surgical disc procedures per-
formed on individuals with herniated discs and degenerative
disc disease. Surgical specimens were transported to the lab-
oratory (less than 30 minutes after surgical removal) in sterile
tissue culture medium and were placed in 10% neutral buff-
ered formalin for no longer than 24 hours. Care was taken to
remove all granulation tissue and to sample only disc tissue.
Donor disc specimens were obtained via the National Cancer
Institute Cooperative Human Tissue Network; the specimens
were shipped overnight to the laboratory in sterile tissue cul-
ture medium and were processed as described below. Spec-
imens were embedded in paraffin without decalcification and
were processed for localization of MMP28 as described
below.
In vivo gene expression of MMP28 and the MMP28 
precursor
Analysis of human disc tissue was carried out as previously
described using laser capture microdissection methods [22].
Annulus gene expression analysis used the Affymetrix microar-
ray system. Total RNA was extracted from cells using the TRI-
zol reagent (Gibco, Carlsbad, CA, USA), reverse transcribed
to double-stranded cDNA, subjected to two rounds of tran-
scription, and hybridized to the DNA microarray in the Affyme-
trix Fluidics Station 400 (Affymetrix, Santa Clara, CA USA).
Affymetrix human U133 X3P arrays were used. The GCOS
Affymetrix GeneChip Operating System (version 1.2) was
used for determining gene expression levels of MMP28
(Affymetrix gene identification number NM_024302.1) and the
MMP28 precursor (Affymetrix gene identification number
AF219624.1). Gene array data were uploaded to the Gene
Expression Omnibus website [GEO:GSE15227] [23].
Immunolocalization of MMP28
Paraffin sections were cut at 4 μm, collected on PLUS slides
(Allegiance, McGaw Park, IL, USA) and dried at 60°C. Sec-
tions were deparaffinized in xylene (Allegiance) and rehydrated
through graded alcohols (AAPER, Shelbyville, KY, USA) to
distilled water. The remainder of the procedure was performed
using the Dako Autostainer Plus (Dako, Carpenteria, CA,
USA) automated stainer. Endogenous peroxidase was
blocked using 3% H2O2 (Sigma, St Louis, MO, USA). Slides
were treated for 5 minutes with Serum-Free Protein Block
(Dako), which was not rinsed off the slides prior to application
of primary antibody. Slides were incubated for 1 hour with anti-
Epilysin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at
a 1:50 dilution. Goat IgG (Vector Laboratories, Burlingame,
CA, USA) was used as a negative control. Secondary antibody
was biotinylated rabbit anti-goat (Vector Laboratories) for 30
minutes followed by 4+ Streptavidin-HRP Label (Biocare
Medical, Concord, CA, USA) for 10 minutes and Dako Auto-
stainer Plus (Dako) for 5 minutes. Slides were removed from
the stainer, rinsed in water, counterstained with light green,
dehydrated, cleared and mounted with resinous mountingAvailable online http://arthritis-research.com/content/11/6/R184
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media. Included with each immunolocalization run were a pos-
itive control (human testis) and negative controls for each
specimen (processed with the absence of the primary anti-
body). Sections adjacent to those used for MMP28 localiza-
tion were stained with H & E and Masson trichrome for general
histologic features.
The number of cells positive for MMP28 immunolocalization
was counted and the percentage of positive cells was deter-
mined. For these cell counts, the mean ± standard deviation
number of cells counted for the outer annulus specimens was
229 ± 64.0 (n = 5), for the inner annulus specimens was 375
± 175 (n = 27), and for the nucleus pulposus specimens was
357 ± 160 (n = 3).
Statistical analyses
Statistical analysis of data utilized standard methods using
SAS software (version 11; SAS Institute, Cary, NC, USA),
including Fisher's exact test, analysis of variance (ANOVA)
and Tukey's test where appropriate, correlation analyses and t
tests. Gene expression data from microarray studies were
tested for normality and were found not to be normally distrib-
uted. These data were therefore log-transformed prior to
ANOVA analyses.
Results
Molecular confirmation of in vivo expression of MMP28 
and the MMP28 precursor gene in the human disc
The in vivo expression of MMP28 was analyzed in annulus tis-
sue from 19 surgical disc specimens (six Thompson Grade I
to II discs, nine Grade III discs, and four Grade IV discs) as
previously described using laser capture microdissection to
harvest disc cells from paraffin-embedded tissues and using
gene expression analysis with a microarray [22]. The MMP28
precursor gene expression was detected in 16 of the speci-
mens. The results are shown in Figure 1 with data related to
the grade of disc degeneration (expressed as mean ± stand-
ard error of the mean). ANOVA analysis of log-transformed
data showed no significant relationship between gene expres-
sion data for MMP28 and the MMP28 precursor and Thomp-
son grades.
In vivo localization of MMP28 in the human 
intervertebral disc
Table 1 summarizes the demographic features of the patient
population studied for immunolocalization of MMP28. Tissue
specimens were analyzed surgical specimens or normal donor
discs; note that some specimens contained more than one site
of disc tissue (outer annulus, inner annulus or nucleus pulpo-
sus). Specimens ranged from healthy Thompson Grade I to
very degenerated Grade V stages of degeneration.
MMP28 was present in the vast majority of annulus cells in the
outer annulus (characterized by prominent lamellar layers of
collagen bundles [24]) (Figure 2). In the inner annulus, locali-
zation was present in some, but not all, cells. Negative cells
were commonly present near cells with positive localization
(Figure 3a). When disc tissue contained clusters of annulus
cells, there again was the finding of the presence in some, but
not all, cells (Figure 3b). Similarly, some cells in the nucleus
pulposus showed the presence of MMP28 (Figure 3c).
MMP28 was not found in the ECM of healthier Grade I to II
discs, but was identified in the ECM of 61% of the more
degenerated Grade III to V discs (P = 0.0018).
Specimens with higher grades of more advanced degenera-
tion showed focal accumulation of ECM localization of
MMP28. Such regions ranged in extent from relative focal,
Figure 1
Gene expression for matrix metalloproteinase 28 and precursor in vivo  in human annulus tissue Gene expression for matrix metalloproteinase 28 and precursor in vivo 
in human annulus tissue. Relative gene expression levels for (a) matrix 
metalloproteinase (MMP) 28 and (b) MMP28 precursor in vivo in 
human annulus tissue according to grades of disc degeneration. Data 
presented as the mean ± standard error of the mean. Values inside 
bars show the number of specimens analyzed for the respective grade 
of disc tissue.Arthritis Research & Therapy    Vol 11 No 6    Gruber et al.
Page 4 of 8
(page number not for citation purposes)
pericellular concentrations around and between cells (Figure
4a) to larger regions of involved matrix that often were near the
site of focal matrix loss (Figure 4b, asterisk). Of the specimens
evaluated that were Grade III or IV, 43.8% showed positive
ECM MMP28 content. All of the specimens that were the most
advanced degenerative grade (Grade V) showed MMP28
localization in the ECM.
Instances were also identified where the encapsulating matrix
surrounding disc cells, previously described in histologic stud-
ies [25], showed the presence of MMP28 (Figure 5).
The percentage of cells positive for MMP28 immunolocaliza-
tion was quantitatively determined in specimens of the outer
annulus, the inner annulus or the nucleus pulposus. When ana-
Table 1
Summary of clinical and demographic features in the study population
Subject number Age (years), gender Thompson grade Vertebral levela Herniation Other information
Young subjects
1 17, female I Lumbar No Normal donor
2 10, female I Lumbar No Normal donor
Adult subjects
3 21, male II L5 to S1 Yes Surgical patient
4 50, male II L3 to L4 Yes Surgical patient
5 46, male II L5 to S1 No Surgical patient
6 41, male II L5 to S1 Yes Surgical patient
7 18, female II L4 to L5 Yes Surgical patient
8 30, male II L3 to L4 No Normal donor; liver cancer
9 30, male III L4 to L5 Yes Surgical patient
10 31, male III L5 to S1 Yes Surgical patient
11 37, male III L5 to S1 Yes Surgical patient
12 40, female III L4 to L5 No Surgical patient
13 41, female III Lumbar No Normal donor
14 38, male III L4 to L5 Yes Surgical patient
15 40, female III L5 to S1 No Surgical patient
16 56, female III L5 to S1 Yes Surgical patient
17 42, male III L5 to S1 No Surgical patient
18 33, female III L1 to L2 No Normal donor, pulmonary embolism
19 37, male 3.5 L4 to L5 Yes Surgical patient
20 41, male IV Lumbar No Normal donor, Hodgkin's lymphoma
21 54, male IV L4 to L5 Yes Surgical patient
22 65, female IV L1 to L2 No Surgical patient
23 61, female V L4 to L5 No Surgical patient
24 41, male V L4 to L5 No Surgical patient
25 72, female V L5 to S1 Yes Surgical patient
26 39, male V L5 to S1 No Surgical patient
27 48, male V L3 to L4 No Surgical patient
28 79, female V L4 to L5 Yes Surgical patient
29 52, female V L5 to S1 No Surgical patient
aL, lumbar; S, sacral.Available online http://arthritis-research.com/content/11/6/R184
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lyzed by site, the outer annulus showed the largest percentage
of positive cells, followed by the inner annulus and then the
nucleus (P = 0.008) (Figure 6). Tukey test analysis showed
that the percentage of cells positive for MMP28 was signifi-
cantly greater in the outer annulus compared with the inner
annulus and compared with the nucleus (P = 0.05).
Analysis was also performed to determine whether the data
showed any effect due to the disc site being herniated or non-
herniated. Herniated discs showed a significantly greater pro-
portion of MMP28-positive cells (77.0 ± 20.8, n = 20)
compared with nonherniated discs (59.3 ± 26.4, n = 15) (P =
0.034).
Data were also analyzed in terms of the Thompson grade of the
disc. Since our sample sizes were small for some grades, data
for healthy Grade I and II discs were pooled, and were ana-
lyzed in comparison with Grade III discs and with pooled
Grade IV and V discs. ANOVA analysis did not reveal any sig-
nificant differences in these data (pooled Grade I and II discs,
62.5 ± 29.9%, n = 12; Grade III discs, 70.1 ± 22.4%, n = 11;
and Grade IV and V discs, 75.8 ± 2,077%, n = 12). There was
also no significant correlation between the percentage of cells
positive for MMP28 localization and subject age.
Discussion
The data presented here show the presence of a new MMP in
the human intervertebral disc. A greater percentage of cells
positive for MMP28 immunolocalization was present in the
outer annulus and in herniated discs. We look forward to future
studies designed to experimentally test and define the role of
this exciting new MMP in the ECM homeostasis of the healthy
disc and its function in the aging and degenerating disc. There
are a number of potentially important roles that MMP28 may
play in the intervertebral disc; these are discussed below.
Extracellular matrix localization of MMP28 in the disc
The regulation of MMP activity is now recognized as an impor-
tant factor in ECM regulation and degradation in the normal
and degenerating intervertebral disc. The findings presented
here - which show that MMP28 immunolocalization was
Figure 2
Cytoplasmic localization of matrix metalloproteinase 28 in cells of the  outer annulus Cytoplasmic localization of matrix metalloproteinase 28 in cells of the 
outer annulus. (a) Cytoplasmic localization of matrix metalloproteinase 
28 in spindle-shaped annulus cells in the outer annulus of a Thompson 
Grade III disc. (b) Negative control processed with goat IgG. Magnifi-
cation: ×450.
Figure 3
Cytoplasmic localization of matrix metalloproteinase 28 in cells of the  inner annulus and nucleus pulposus Cytoplasmic localization of matrix metalloproteinase 28 in cells of the 
inner annulus and nucleus pulposus. (a) Cytoplasmic localization of 
matrix metalloproteinase (MMP) 28 in cells of the inner annulus of a 
Thompson Grade III disc. Note the negative cells (arrows) that lie near 
a cell with positive expression. (b) Inner annulus cells in clusters in a 
Thompson Grade III disc. Note the presence of both positive and nega-
tive (arrows) cells. (c) Some, but not all, cells show MMP28 localization 
in the nucleus pulposus of this Thompson grade IV disc. Magnification: 
(a) ×400, (b) ×580, (c) ×360.Arthritis Research & Therapy    Vol 11 No 6    Gruber et al.
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absent in the ECM of healthier Grade I to II discs, but was
present in the ECM of 61% of the more degenerated Grade III
to V discs (P = 0.0018) - provides novel evidence supporting
previous data pointing to a role of MMP28 ECM homeostasis
[15]. It is worth commenting here that the deposition of
MMP28 within the ECM may represent the result of previous
episodes of high MMP28 expression.
Heiskanen and colleagues reported finding overexpressed
MMP28 in the insoluble basolateral ECM of cultured confluent
epithelial cells [26]. MMP28 was also present in intact base-
ment membrane in wound studies [15], where its expression
was seen to be spatially and temporally regulated. Recent
research has shown the presence of MMP28 in cartilage and
synovium; MMP28 was one of the four most significantly
upregulated genes in osteoarthritis [7,27,28], suggesting a
role for MMP28 in association with cartilage degradation and/
or regeneration. (Unfortunately, the work of Kevorkian and col-
leagues [28] and that of Davidson and colleagues [27] in oste-
oarthritis did not include immunohistochemical studies of the
cartilage matrix, so we do not know whether ECM localization
of MMP28 was present).
Figure 4
Localization of matrix metalloproteinase 28 in the extracellular matrix of  the inner annulus Localization of matrix metalloproteinase 28 in the extracellular matrix of 
the inner annulus. Localization of matrix metalloproteinase 28 in the 
extracellular matrix in the inner annulus of a Thompson Grade V disc. 
Both (a) relatively small, localized pericellular (arrows) concentrations 
and (b) diffuse larger localization regions were present in the disc 
matrix of more degenerated discs. *Nearby presence of focal regions of 
matrix loss in a Thompson Grade III disc. Magnification: (a) ×325, (b) 
×110.
Figure 5
Positive localization of matrix metalloproteinase 28 in the inner annulus Positive localization of matrix metalloproteinase 28 in the inner annulus. 
Positive localization of matrix metalloproteinase 28 within the pericellu-
lar encapsulation matrix (arrows) of cells in the inner annulus of a 
Thompson Grade II disc. Magnification: ×465.
Figure 6
Percentage of cells positive for matrix metalloproteinase 28  immunolocalization Percentage of cells positive for matrix metalloproteinase 28 immunolo-
calization. The percentage of cells positive for matrix metalloproteinase 
(MMP) 28 immunolocalization was quantitatively determined. When 
analyzed by site, the outer annulus showed the largest percentage of 
positive cells, followed by the inner annulus and then the nucleus (P = 
0.008, analysis of variance).Available online http://arthritis-research.com/content/11/6/R184
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MMP28 and TNFα
Recent studies on matrix synthesis and degradation in the disc
have shown that proinflammatory cytokines, such as TNFα, are
important cytokines involved in the pathogenesis of disc
degeneration. TNFα is elevated in the degenerating disc,
induces changes in the biochemical features of discs, notably
a loss in proteogycans, stimulates production of nerve growth
factor [29], and has been found to regulate MMP3 in nucleus
pulposus cells [30]. Saarialho-Kere and colleagues have
shown that TNFα induces the expression of MMP28 in cul-
tured primary keratinocytes [15]. MMP28 was not induced,
however, by exposure of cells to a number of other cytokines,
including basic fibroblast growth factor, epidermal growth fac-
tor, granulocyte-macrophage colony-stimulating factor, hepa-
tocyte growth factor, IFNγ, IL-1β (a proinflammatory cytokine
also involved in disc degeneration), platelet-derived growth
factor, transforming growth factor beta (TGFβ), vascular
endothelial growth factor, or insulin-like growth factor 1. Our
new finding of the presence of MMP28 in the disc may thus be
associated with matrix degradation via involvement of TNFβ.
MMP28 and transforming growth factor beta
MMP28 may have a connection with another cytokine that has
importance in the disc. TGFβ1, a cytokine well known for reg-
ulating connective tissue metabolism, is present in the disc
and is an agent suggested to be associated with changes in
the disc ECM during degeneration [31-34]. Illman and col-
leagues found that lung adenocarcinoma cells that expressed
recombinant MMP28 showed this transition with a loss of cell
surface E-cadherin [35,36], and showed proteolytic process-
ing of latent TGFβ complexes with a resulting increased level
of active TGFβ [35]. Disc tissue with higher concentrations of
MMP28 may also have the potential of contributing to elevated
TGFβ levels.
The degenerating disc and herniation and loading
A number of studies have indicated that mechanical load
induces MMP expression/activation (see [37] for a review),
especially in the aging/degenerating disc [10,38,39]. In our
present work, we found a significantly greater proportion of
cells with MMP28 immunolocalization in herniated discs com-
pared with nonherniated discs. There is some evidence that
mechanical compression can produce a very large release of
active MMP28 in heterotrophic scars; these findings may sug-
gest that MMP28 may play a role in restructuring the ECM dur-
ing loading and healing conditions [16]. It may therefore be
important for future studies of MMP28 in the disc to assess its
expression in models designed to assess loading and disc
matrix failure and herniation. It should also be noted that
although the degradative changes in the disc are well recog-
nized in the nucleus pulposus, here we saw a high proportion
of cellular immunolocalization of MMP28 in the outer annulus,
which may relate to biochemical stress patterns in the outer
lamellar regions of degenerating discs.
Conclusions
The findings presented here show the first documentation of
intervertebral disc expression and production of MMP28, a
recently identified MMP. Data are important because of the key
role of MMPs in disc turnover and homeostasis, and because
of previous findings that pointed to a role for this MMP in matrix
repair. Both cytoplasmic and ECM localization of MMP28 was
present within the disc, with a greater proportion of cells with
MMP28 immunolocalization in the outer annulus compared
with the inner annulus and nucleus pulposus. A significantly
greater cellular localization was also found in herniated discs
compared with nonherniated discs. MMP28 was absent in the
ECM of healthier Grade I to II discs, but was present in the
ECM of 61% of the more degenerated Grade III to V discs (P
= 0.0018). The results presented here point to the importance
of future studies exploring the potential role of MMP28 in disc
matrix homeostasis and turnover.
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